107 related articles for article (PubMed ID: 28779425)
1. Association of fetuin-A to adiponectin ratio with metabolic syndrome: a cross-sectional study.
Ju H; Zhou Z; Sun M; Chen H
Endocrine; 2017 Oct; 58(1):190-193. PubMed ID: 28779425
[No Abstract] [Full Text] [Related]
2. Fetuin-A is also an adipokine.
Jialal I; Pahwa R
Lipids Health Dis; 2019 Mar; 18(1):73. PubMed ID: 30917813
[TBL] [Abstract][Full Text] [Related]
3. Fetuin-a to adiponectin ratio is a sensitive indicator for evaluating metabolic syndrome in the elderly.
Zhou Z; Sun M; Jin H; Chen H; Ju H
Lipids Health Dis; 2020 Apr; 19(1):61. PubMed ID: 32252782
[TBL] [Abstract][Full Text] [Related]
4. Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistance.
Rametta R; Ruscica M; Dongiovanni P; Macchi C; Fracanzani AL; Steffani L; Fargion S; Magni P; Valenti L
Eur J Clin Invest; 2014 Jul; 44(7):627-33. PubMed ID: 24828988
[TBL] [Abstract][Full Text] [Related]
5. Serum adiponectin and fetuin-A levels in children with nephrotic syndrome.
El-Mashad GM; Essa SM
Egypt J Immunol; 2011; 18(1):17-23. PubMed ID: 23082476
[TBL] [Abstract][Full Text] [Related]
6. The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease.
Celebi G; Genc H; Gurel H; Sertoglu E; Kara M; Tapan S; Acikel C; Karslioglu Y; Ercin CN; Dogru T
Saudi J Gastroenterol; 2015; 21(3):139-45. PubMed ID: 26021772
[TBL] [Abstract][Full Text] [Related]
7. Higher fetuin-A level is associated with coexistence of elevated alanine aminotransferase and the metabolic syndrome in the general population.
Koch M; Jacobs G; Hampe J; Rosenstiel P; Krawczak M; Nöthlings U
Metab Syndr Relat Disord; 2013 Dec; 11(6):377-84. PubMed ID: 23971757
[TBL] [Abstract][Full Text] [Related]
8. Involvement of resveratrol in crosstalk between adipokine adiponectin and hepatokine fetuin-A in vivo and in vitro.
Lee HJ; Lim Y; Yang SJ
J Nutr Biochem; 2015 Nov; 26(11):1254-60. PubMed ID: 26282595
[TBL] [Abstract][Full Text] [Related]
9. Higher fetuin-A, lower adiponectin and free leptin levels mediate effects of excess body weight on insulin resistance and risk for myelodysplastic syndrome.
Dalamaga M; Karmaniolas K; Chamberland J; Nikolaidou A; Lekka A; Dionyssiou-Asteriou A; Mantzoros CS
Metabolism; 2013 Dec; 62(12):1830-9. PubMed ID: 24140093
[TBL] [Abstract][Full Text] [Related]
10. Relationship between disease severity and fetuin-A levels in patients with psoriasis.
Shehata WA; Basha MA; Gayed IM; Elhagary SB
Indian J Dermatol Venereol Leprol; 2020; 86(5):586-588. PubMed ID: 32769317
[No Abstract] [Full Text] [Related]
11. Relationship of serum fetuin-A levels with coronary atherosclerotic burden and NAFLD in patients undergoing elective coronary angiography.
Ballestri S; Meschiari E; Baldelli E; Musumeci FE; Romagnoli D; Trenti T; Zennaro RG; Lonardo A; Loria P
Metab Syndr Relat Disord; 2013 Aug; 11(4):289-95. PubMed ID: 23600632
[TBL] [Abstract][Full Text] [Related]
12. Role of Thyroid Deficiency on Adiponectin, Leptin, and Metabolic Status in Visceral Obesity: A Cross-Sectional Study.
Lozanov LB; Gorcheva D; Lozanov BS; Argirova R; Koleva V; Kostova B; Borisov RP; Nedeva M
Horm Metab Res; 2017 Sep; 49(9):667-672. PubMed ID: 28728192
[TBL] [Abstract][Full Text] [Related]
13. Acute effects of hyperglycaemia on asymmetric dimethylarginine (ADMA), adiponectin and inflammatory markers (IL-6, hs-CRP) in overweight and obese women with metabolic syndrome.
Siervo M; Corander M; Mander AP; Browning LM; Jebb SA
Br J Biomed Sci; 2010; 67(4):216-8. PubMed ID: 21294450
[No Abstract] [Full Text] [Related]
14. Plasma fetuin-A is associated with endothelial dysfunction and subclinical atherosclerosis in subjects with nonalcoholic fatty liver disease.
Dogru T; Genc H; Tapan S; Aslan F; Ercin CN; Ors F; Kara M; Sertoglu E; Karslioglu Y; Bagci S; Kurt I; Sonmez A
Clin Endocrinol (Oxf); 2013 May; 78(5):712-7. PubMed ID: 22676641
[TBL] [Abstract][Full Text] [Related]
15. Association between dietary factors and plasma fetuin-A concentrations in the general population.
Nimptsch K; Janke J; Pischon T; Linseisen J
Br J Nutr; 2015 Oct; 114(8):1278-85. PubMed ID: 26316198
[TBL] [Abstract][Full Text] [Related]
16. Association of mitral annular calcification with endothelial dysfunction, carotid intima-media thickness and serum fetuin-A: an observational study.
Ziyrek M; Tayyareci Y; Yurdakul S; Sahin ST; Yıldırımtürk O; Aytekin S
Anadolu Kardiyol Derg; 2013 Dec; 13(8):752-8. PubMed ID: 24108756
[TBL] [Abstract][Full Text] [Related]
17. Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.
Ou HY; Yang YC; Wu HT; Wu JS; Lu FH; Chang CJ
J Clin Endocrinol Metab; 2012 Dec; 97(12):4717-23. PubMed ID: 23066121
[TBL] [Abstract][Full Text] [Related]
18. Fetuin-A in Metabolic syndrome: A systematic review and meta-analysis.
Pan X; Wen SW; Bestman PL; Kaminga AC; Acheampong K; Liu A
PLoS One; 2020; 15(3):e0229776. PubMed ID: 32134969
[TBL] [Abstract][Full Text] [Related]
19. Serum Fetuin-A Levels and Thyroid Function inMiddle-aged and Elderly Chinese.
Deng XR; Ding L; Wang TG; Xu M; Lu JL; Li M; Zhao ZY; Chen YH; Bi YF; Xu YP; Xu Y
Biomed Environ Sci; 2017 Jun; 30(6):455-459. PubMed ID: 28705270
[TBL] [Abstract][Full Text] [Related]
20. Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies.
Haukeland JW; Dahl TB; Yndestad A; Gladhaug IP; Løberg EM; Haaland T; Konopski Z; Wium C; Aasheim ET; Johansen OE; Aukrust P; Halvorsen B; Birkeland KI
Eur J Endocrinol; 2012 Mar; 166(3):503-10. PubMed ID: 22170794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
